Drugs give FTSE a lift

clock

The FTSE 100 index has lost 28.6 points, or 0.5%, to 5,856 points this morning, led by AstraZeneca.

Drug giant AstraZeneca has slipped back 1.04% to £32.30 after ING Financial changed its “buy” recommendation to “hold” as it awaits key developments over the next few months. William Morrison has fallen 0.62% to 200.5p after HSBC rated it as "overweight" with a price target of 240p. Sainsbury has been started with an 'underweight' recommendation and has fallen 0.22% to 334.25p. In Japan, the Nikkei 225 Stock Average added 66.88 points, or 0.4%, to 15,638.5 points as a US manufacturing report fuelled speculation the Federal Reserve might refrain from raising interest rates. Sony ...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Rathbones brings together responsible investment in Centre of Excellence

Rathbones brings together responsible investment in Centre of Excellence

Combines ethical and sustainable research capabilities

Patrick Brusnahan
clock 29 May 2026 • 1 min read
Why active management matters more for income investors

Why active management matters more for income investors

Significant implications for advisers and investors relying on passive income strategies

Rory Sandilands
clock 29 May 2026 • 4 min read
Can the energy crisis power renewables past their headwinds?

Can the energy crisis power renewables past their headwinds?

Renewables continue to see headwinds

Ian Aylward
clock 28 May 2026 • 3 min read